MiR-92a family and their target genes in tumorigenesis and metastasis

Experimental Cell Research

Volumn 323, Issue 1, 2014, Pages 1-6

  Li, Molin ^a   Guan, Xingfang ^a   Sun, Yuqiang ^a   Mi, Jun ^a   Shu, Xiaohong ^a   Liu, Fang ^a   Li, Chuangang ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

MiR 92a family; Regulation; Target genes; Tumors

Indexed keywords

BETA CATENIN; CADHERIN; CELL SURFACE RECEPTOR; DESMOCOLLIN; INTEGRIN; MICRORNA; MICRORNA 25; MICRORNA 363; MICRORNA 92A; MICRORNA 92A 1; MICRORNA 92A 2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UVOMORULIN; WNT PROTEIN;

APOPTOSIS; BREAST CARCINOMA; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL ADHESION; CELL JUNCTION; CYTOPLASM; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC REGULATION; HUMAN; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIPLE CANCER; OVARY CANCER; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR INVASION; WNT SIGNALING PATHWAY;

MIR-92A FAMILY; REGULATION; TARGET GENES; TUMORS;

APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84896495128     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.12.025     Document Type: Review

References (61)

1. He L., Thomson J.M., Hemann M.T., et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435(7043):828-833.
2. Bonauer A., Carmona G., Iwasaki M., et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324(5935):1710-1713.
3. Santoro M.M., Nicoli S. miRNAs in endothelial cell signaling: the endo miRNAs. Exp. Cell. Res. 2013, 319(9):1324-1330.
4. Kaluza D., Kroll J., Gesierich S., et al. Histone deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2013, 33(3):533-543.
5. Olive V., Jiang I., He L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 2010, 42(8):1348-1354.
6. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133(2):217-222.
7. Ota A., Tagawa H., Karnan S., et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 2004, 64(9):3087-3095.
8. Landais S., Landry S., Legault P., et al. Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res. 2007, 67(12):5699-5707.
9. Ventura A., Young A.G., Winslow M.M., et al. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 2008, 132(5):875-886.
10. Suarez Y., Fernandez-hernando C., Yu J., et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc. Nat. Acad. Sci. U.S.A. 2008, 105(37):14082-14087.
11. Lu Y., Thomson J.M., Wong H.Y., et al. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 2007, 310(2):442-453.
12. Wang Q., Li Y.C., Wang J., et al. miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc. Nat. Acad. Sci. U.S.A. 2008, 105(8):2889-2894.
13. Kumar P., Luo Y., Tudela C., et al. The c-Myc-regulated microRNA-17~92 (miR-17~92) and miR-106a~363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation. Mol. Cell Biol. 2013, 33(9):1782-1796.
14. Volinia S., Calin G.A., Liu C.G., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Nat. Acad. Sci. U.S.A. 2006, 103(7):2257-2261.
15. Zhou T., Zhang G., Liu Z., et al. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Int. J. Colorectal Dis. 2013, 28(1):19-24.
16. Valera V.A., Walter B.A., Linehan W.M., et al. Regulatory effects of microRNA-92 (miR-92) on VHL Gene expression and the hypoxic activation of miR-210 in clear cell renal cell carcinoma. J. Cancer 2011, 2:515-526.
17. Ranade A.R., Cherba D., Sridhar S., et al. MicroRNA 92a-2: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J. Thorac. Oncol. 2010, 5(8):1273-1278.
18. Shigoka M., Tsuchida A., Matsudo T., et al. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol. Int. 2010, 60(5):351-357.
19. Yoshizawa S., Ohyashiki J.H., Ohyashiki M., et al. Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders. Blood Cancer J. 2012, 2(1):e53.
20. Ohyashiki K., Umezu T., Yoshizawa S., et al. Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma. PLoS One 2011, 6(2):e16408.
21. Si H., Sun X., Chen Y., et al. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J. Cancer Res. Clin. Oncol. 2013, 139(2):223-229.
22. Nilsson S., Möller C., Jirström K., et al. Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration. PLoS One 2012, 7(4):e36051.
23. Ohyashiki J.H., Umezu T., Kobayashi C., et al. Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a. BMC Res. Notes 2010, 3:347.
24. Petrocca F., Vecchione A., Croce C.M., et al. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 2008, 68(20):8191-8194.
25. Zhang H., Zuo Z., Lu X., et al. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol. Rep. 2012, 27(2):594-598.
26. Poliseno L., Salmena L., Riccardi L., et al. Identification of the miR-106b? 25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci. Signal. 2010, 3(117). (ra29).
27. Fang W.K., Liao L.D., Li L.Y., et al. Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signaling in esophageal squamous cell carcinoma. J. Pathol. 2013, 231(2):257-270.
28. Nishida N., Nagahara M., Sato T., et al. Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic microRNA clusters. Clin. Cancer Res. 2012, 18(11):3054-3070.
29. Sun Q., Zhang J., Cao W., et al. Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int. J. Biochem. Cell Biol. 2013, 45(3):513-520.
30. Zhang L., Huang J., Yang N., et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Nat. Acad. Sci. U.S.A. 2006, 103(24):9136-9141.
31. Liu Y., Zhang Y., Wen J., et al. A genetic variant in the promoter region of miR-106b-25 cluster and risk of HBV infection and hepatocellular carcinoma. PLoS One 2012, 7(2):e32230.
32. Sevignani C., Calin G.A., Nnadi S.C., et al. MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc. Nat. Acad. Sci. U.S.A. 2007, 104(19):8017-8022.
33. Makunin I.V., Pheasant M., Simons C., et al. Orthologous microRNA genes are located in cancer-associated genomic regions in human and mouse. PLoS One 2007, 2(11):e1133.
34. Kunej T., Godnic I., Ferdin J., et al. Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat. Res. 2011, 717(1-2):77-84.
35. Grillari J., Hackl M., Grillari-Voglauer R. miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology 2010, 11(4):501-506.
36. Ji M., Rao E., Ramachandrareddy H., et al. The miR-17-92 MicroRNA cluster is regulated by multiple mechanisms in B-cell malignancies. Am. J. Pathol. 2011, 179(4):1645-1656.
37. DeGregori J. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim. Biophys. Acta 2002, 1602(2):131-150.
38. Pierce A.M., Schneider-Broussard R., Gimenez-Conti I.B., et al. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model. Mol. Cell Biol. 1999, 19(9):6408-6414.
39. Sylvestre Y., De Guire V., Querido E., et al. An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem. 2007, 282(4):2135-2143.
40. Petrocca F., Visone R., Onelli M.R., et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13(3):272-286.
41. Schulte J.H., Horn S., Otto T., et al. MYCN regulates oncogenic microRNAs in neuroblastoma. Int. J. Cancer 2008, 122(3):699-704.
42. Aguda B.D., Kim Y., Piper-Hunter M.G., et al. MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc. Nat. Acad. Sci. U.S.A. 2008, 105(50):19678-19683.
43. Stallings R.L. MicroRNA involvement in the pathogenesis of neuroblastoma: potential for microRNA mediated therapeutics. Curr. Pharm. Des. 2009, 15(4):456-462.
44. Zhao Z.N., Bai J.X., Zhou Q., et al. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC. PLoS One 2012, 7(9):e45133.
45. Yan H.L., Xue G., Mei Q., et al. Repression of the miR-17-92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 2009, 28(18):2719-2732.
46. Brock M., Trenkmann M., Gay R.E., et al. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway. Circ. Res. 2009, 104(10):1184-1191.
47. Yu Z., Wang C., Wang M., et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J. Cell Biol. 2008, 182(3):509-517.
48. Smith A.L., Iwanaga R., Drasin D.J., et al. The miR-106b-25 cluster targets Smad7, activates TGF-b signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer. Oncogenesis 2012, 31(50):5162-5171.
49. Rao E., Jiang C., Ji M., et al. The miRNA-17-92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia 2012, 26(5):1064-1072.
50. Ghosh A.K., Shanafelt T.D., Cimmino A., et al. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 2009, 113(22):5568-5574.
51. Kim Y.K., Yu J., Han T.S., et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009, 37(5):1672-1681.
52. Niu H., Wang K., Zhang A., et al. miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. Oncol. Rep. 2012, 28(5):1771-1777.
53. Tsuchida A., Ohno S., Wu W., et al. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer. Cancer Sci. 2011, 102(12):2264-2271.
54. Kan T., Sato F., Ito T., et al. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009, 136(5):1689-1700.
55. Kumar M., Lu Z., Takwi A.A., et al. Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogenesis 2011, 30(7):843-853.
56. Suh S.S., Yoo J.Y., Nuovo G.J., et al. MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc. Nat. Acad. Sci. U.S.A. 2012, 109(14):5316-5321.
57. Razumilava N., Bronk S.F., Smoot R.L., et al. miR-25 targets TRAIL death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology 2012, 55(2):465-475.
58. Missan D.S., DiPersio M. Integrin control of tumor invasion. Crit. Rev. Eukaryot. Gene Exp. 2012, 22(4):309-324.
59. Ohyagi-Hara C., Sawada K., Kamiura S., et al. miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression. Am. J. Pathol. 2013, 182(5):1876-1889.
60. Xu X., Chen Z., Zhao X., et al. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem. Biophys. Res. Commun. 2012, 421(4):640-645.
61. Chen Z.L., Zhao X.H., Wang J.W., et al. MicroRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J. Biol. Chem. 2011, 286(12):10725-10734.